↧
HST Partners bolsters commitment to green enzyme developer MetGen
European investment firm HST Partners has strengthened its commitment to Finnish disruptive enzymatic products developer MetGen by making another investment after participating in a recent fundraiser.
View ArticleEmerald makes inaugural investment from fund III into MetGen
Emerald Technology Ventures has made the first investment from its third fund by backing Finnish industrial biotech business MetGen.
View ArticleDeal round-up: European bioenergy shows strong growth
Bioenergy companies throughout Europe made a series of deals, particularly in Western Europe, that will strengthen the technologies presence throughout the region.
View Article